NCT07167160RecruitingPhase 2
Chemo-immunotherapy for Cervical Cancer Stage IIICp Trial
Camrelizumab Combined With Chemotherapy for Adjuvant Treatment of Cervical Cancer Patients With Pathologically Confirmed Lymph Node Positivity After Stage Surgery: A Prospective, Single-Arm, Multicenter, Phase II Clinical Trial
Source: ClinicalTrials.gov · Last updated 18 Dec 2025
Brief summary (registry, in English)
Efficacy evaluation of camrelizumab combined with chemotherapy for adjuvant treatment of patients with pathologically confirmed lymph node-positive cervical cancer after staging surgery.
- Status (registry)
- Recruiting
- Phase (registry)
- Phase 2
- Study type
- Interventional
- Enrollment
- 59 (estimated)
- First submitted
- 1 Sept 2025
- Start date
- Mar 2025
- Primary completion date
- Dec 2026
- Lead sponsor
- Women's Hospital School Of Medicine Zhejiang University
- Diseases
- Cervical cancer
- NCT number
- NCT07167160
What you commit to
- Study type: Interventional · Phase 2
- Planned participants: 59
- From Mar 2025 to the primary completion date, Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Positive parametrium or surgical margin;
- Incomplete radical surgery;
- Previous treatment with immune checkpoint inhibitors.
Other illness
- Active autoimmune disease or autoimmune disease requiring systemic treatment;
Other
- Residual target lesions;
Who the study is looking for
- Patients with cervical cancer staged FIGO2018 IIIC1p or IIIC2p after radical surgery;
- Positive PD-L1 expression;
- ECOG score ≤1
Age in the registry: 18 years to 70 years · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Women's hospital school of medicine Zhejiang University Coordinator of this site? Confirm its status | Hangzhou | China | Recruiting |
Related publications
This page is information, not medical advice. Discuss any trial with your doctor.